Company page

Verici Dx Plc

Verici Dx Plc, trading under the ticker VRCI, is a public company listed in the UK with a market capitalization of approximately £7.49 million. The company focuses on developing innovative diagnostic solutions for organ transplant patients. Its mission is to improve patient outcomes through advanced technology and personalized medicine.